Publications
Detailed Information
Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea's National Health Insurance
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Bong-min | - |
dc.contributor.author | Bae, Eun-young | - |
dc.contributor.author | Kim, Jinhyun | - |
dc.date.accessioned | 2009-09-24T23:37:46Z | - |
dc.date.available | 2009-09-24T23:37:46Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Health Affairs 27, no.1 (2008): 179-187 | en |
dc.identifier.issn | 0278-2715 | - |
dc.identifier.uri | https://hdl.handle.net/10371/9795 | - |
dc.description.abstract | South Koreas National Health Insurance recently announced a reform in pharmaceutical reimbursement, with the purpose of increasing rational resource use in drug spending. The new policy aims to take the cost-effectiveness and budget impact of newly introduced drugs into account in payment decisions. If the policy is implemented, South Korea will be the first Asian country to officially adopt economic evaluation as a tool for resource allocation in health care. This paper looks at the background, objectives, expected outcomes, potential issues, and resulting trade conflict regarding use of economic data in drug reimbursement decisions in South Korea. | en |
dc.language.iso | en | - |
dc.publisher | Project HOPE | en |
dc.title | Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea's National Health Insurance | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 양봉민 | - |
dc.contributor.AlternativeAuthor | 배은영 | - |
dc.contributor.AlternativeAuthor | 김진현 | - |
dc.identifier.doi | 10.1377/hlthaff.27.1.179 | - |
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.